TITLE

Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn's disease

AUTHOR(S)
Coccia, E. M.; Remoli, M. E.; Di Giacinto, C.; Del Zotto, B.; Giacomini, E.; Monteleone, G.; Boirivant, M.
PUB. DATE
November 2005
SOURCE
Gut;Nov2005, Vol. 54 Issue 11, p1558
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Cholera toxin B subunit (CT-B) is a powerful modulator of immune responses. The authors have previously demonstrated that oral administration of recombinant CT-B (rCT-B) is able to prevent and cure the Crohn's disease (CD)-like trinitrobenzene sulfonic acid (TNBS) mediated colitis. In this study they extended their observations and examined if rCT-B interferes with the molecular signaling underlying the Th1 type response both in TNBS colitis and in ex vivo human CD explants. Methods: TNBS treated mice were fed with rCT-B, and IFN-γ and IL- 12 production by colonic lamina propria mononuclear cells (LPMC) was examined by ELISA. In vitro culture of mucosal explants from CD patients and non-inflammatory bowel disease controls, pre-incubated with rCT-B, were examined for IFN-γ and IL-12 production by ELISA and semiquantitative reverse transcription polymerase chain reactions. STAT-1, -4, -6 activation and T-bet expression were examined following rCT-B treatment by western blotting both in TNBS treated mice and in human mucosol explants. Results: rCT-B significantly reduced IL-12 and IFN-γ secretion by LPMC from TNBS treated mice. Consistent with this, rCT-B inhibited both STAT-4 and STAT-1 activation and downregulated T-bet expression. Inhibition of Th1 signaling by CT-B associated with no change in IL-4 synthesis and expression of active STAT-6 indicating that rCT-B does not enhance Th2 cell responses. Moreover, in vitro treatment of CD mucosal explants with rCT-B resulted in reduced secretion of IL-12/IFN-γ and inhibition of STAT-4/STAT-1 activation and T-bet expression. Conclusions: These studies indicate that CT-B inhibits mucosal Th1 cell signaling and suggest that rCT-B may be a promising candidate for CD therapy.
ACCESSION #
18830600

 

Related Articles

  • NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population. Zhang, Hong-xin; Wang, Zheng-ting; Lu, Xiong-xiong; Wang, Yan-gui; Zhong, Jie; Liu, Jie // Inflammation Research;Dec2014, Vol. 63 Issue 12, p979 

    Objective: This study aimed to investigate whether NLRP3 is associated with IBD in Chinese Han population. Methods: Three SNPs were genotyped using polymerase chain reaction with sequence-specific primers in 288 patients [232 Crohn's disease (CD) patients, 56 ulcerative colitis (UC) patients]...

  • Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease. Fasseu, Magali; Tréton, Xavier; Guichard, Cé cile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soulé, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, André; Ogier-Denis, Eric // PLoS ONE;2010, Vol. 5 Issue 10, p1 

    Background: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa. Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response. We...

  • The Role of Cytokine Gene Polymorphisms in Determining Disease Susceptibility and Phenotype in Inflammatory Bowel Disease. Cantor, Michael J.; Nickerson, Peter; Bernstein, Charles N. // American Journal of Gastroenterology;May2005, Vol. 100 Issue 5, p1134 

    BACKGROUND AND AIMS: Emerging data indicate that alterations in cytokine synthesis may play a role in inflammatory bowel disease (IBD) pathogenesis. The differential production of cytokines has been linked to single nucleotide polymorphisms in gene promoter regions, signal sequences, and gene...

  • OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease. Mei Li; Xiang Gao; Chang-Cun Guo; Kai-Chun Wu; Xin Zhang; Pin-Jin Hu; McCormick, Beth A. // World Journal of Gastroenterology;8/21/2008, Vol. 14 Issue 31, p4923 

    AIM: To investigate the single nucleotide polymorphism (SNPs) distribution of NOD2/CARD15 (R702W, G908R), OCTN1 1672C/T and OCTN2-207G/C in Chinese patients with inflammatory bowel disease (IBD). METHODS: A total of 61 patients with Crohn's disease (CD), 151 patients with ulcerative colitis...

  • NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. Özen, Senem Ceren; Daǧlı, Ülkü; Kiliç, Mesut Yalin; Törüner, Murat; Çelik, Yasemin; Özkan, Muhip; Soykan, Irfan; Çetinkaya, Hülya; Ülker, Aysel; Özden, Ali; Bozdayı, A. Mithat // Journal of Gastroenterology;Apr2006, Vol. 41 Issue 4, p304 

    Purpose. The genetic susceptibility of people with certain NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene variants to inflammatory bowel disease is still under investigation. The aim of this study was to investigate polymorphisms in the NOD2/CARD15 (R702W, G908R, and 3020insC), NOD1/CARD4 (E266K,...

  • Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid. Kabeerdoss, Jayakanthan; Jayakanthan, Prabavathi; Pugazhendhi, Srinivasan; Ramakrishna, Balakrishnan S. // Indian Journal of Medical Research;Jul2015, Vol. 142 Issue 1, p23 

    Background & objectives: Alterations in microbial communities closely associated with the intestinal mucosa are likely to be important in the pathogenesis of inflammatory bowel disease (IBD). We examined the abundance of specific microbial populations in colonic mucosa of patients with...

  • Evolving paradigms in the pathogenesis of IBD. Mayer, Lloyd // Journal of Gastroenterology;Jan2010, Vol. 45 Issue 1, p9 

    The pathogenesis of all immune-mediated inflammatory diseases has been carefully studied over the past several decades, but it is only recently that we have come to appreciate common pathways and genes. This is especially true for the inflammatory bowel diseases (IBD) Crohn’s disease and...

  • 100 Genes for IBD… Whatever Next!? Lee, James C.; Parkes, Miles // Inflammatory Bowel Disease Monitor;2011, Vol. 11 Issue 3, p103 

    The advent of genome-wide association scanning has revolutionized the search for genetic loci associated with IBD. Recent meta-analyses from the International IBD Genetics Consortium have increased the number of confirmed IBD susceptibility genes and loci to 100. While this represents major...

  • The Role of N-Acetyltransferase 2 Polymorphism in the Etiopathogenesis of Inflammatory Bowel Disease. Baranska, M.; Trzcinski, R.; Dziki, A.; Rychlik-Sych, M.; Dudarewicz, M.; Skretkowicz, J. // Digestive Diseases & Sciences;Jul2011, Vol. 56 Issue 7, p2073 

    Background and Purpose: Inflammatory bowel disease (IBD) consists of ulcerative colitis (UC) and Crohn's disease (CD), which are complex genetic disorders resulting from the interplay between several genetic and environmental risk factors. The arylamine N-acetyltransferase 2 (NAT2) enzyme...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics